If you are pregnant and have vitiligo, you may be wondering whether you can continue — or start — narrowband UVB (NB-UVB) phototherapy. Is it safe for your baby? Will it harm your pregnancy? And what do dermatologists actually recommend?

Here is what the medical evidence and expert guidelines say about using NB-UVB phototherapy for vitiligo during pregnancy.

What Doctors Want You to Know Before Starting Treatment

1. Folic Acid Supplementation Is Essential

This is the most critical precaution. NB-UVB phototherapy can deplete your body's folate levels.

A 2021 clinical study published in Caspian Journal of Internal Medicine found that serum folate levels decreased significantly in patients after 30 sessions of NB-UVB therapy, dropping from an average of 2.76 ng/mL at baseline to 1.34 ng/mL after treatment. The cumulative dose averaged 40.35 J/cm².

Why does this matter? Folate (also known as folic acid) is essential for proper neural tube development in the fetus. A folate deficiency during the first trimester increases the risk of birth defects involving the brain, spine, and spinal cord.

What doctors recommend: If you undergo NB-UVB phototherapy while pregnant, you should take a folic acid supplement and discuss the appropriate dosage with your obstetrician and dermatologist. Many doctors recommend higher doses than the standard prenatal vitamin provides for patients receiving regular phototherapy.

2. Targeted vs. Whole-Body Phototherapy Matters

Not all NB-UVB is the same when it comes to pregnancy. Some clinical protocols distinguish between whole-body phototherapy and targeted approaches.

Some sources note that whole-body phototherapy may be relatively contraindicated during pregnancy, while targeted phototherapy (such as using a handheld NB-UVB device on specific vitiligo patches) is considered medically appropriate. The reasoning is straightforward: limiting UV exposure to only the affected areas reduces total UV dose to the body.

If your vitiligo is localized to a few patches, a targeted device or focused treatment approach may be preferable to full-body light boxes. Discuss this distinction with your dermatologist.

3. Facial Protection Is Important

Using phototherapy during pregnancy increases the risk of developing melasma — patches of darker skin on the face, often called the "mask of pregnancy".

What doctors recommend: Protect your face from UV exposure during treatments, and be especially diligent about sun protection between sessions. Wear broad-spectrum sunscreen and consider physical barriers like hats when outdoors.

4. Treatment Should Follow the "Lowest Effective Dose" Principle

The guiding philosophy for any medical treatment during pregnancy is using the lowest effective dose that adequately controls your condition-19. This is not the same as using no treatment, which can lead to poorly controlled vitiligo with its own implications for maternal well-being.

Your dermatologist will typically start with a conservative UV dose and increase it gradually, monitoring your skin's response at each visit.

5. First Trimester Requires Extra Caution

Some doctors exercise additional caution during the first trimester, when the fetus is undergoing organ development. While NB-UVB is not known to be teratogenic, many dermatologists prefer to minimize all non-essential interventions during this critical period if possible.

If your vitiligo is stable and not progressing rapidly, your doctor may suggest waiting until the second trimester to begin phototherapy, or using only topical treatments during the first three months.

What About PUVA? A Clear Distinction

It is essential to distinguish NB-UVB from PUVA (psoralen plus UVA) phototherapy. PUVA is not safe during pregnancy.

Psoralens (the medications taken or applied before UVA exposure) are mutagenic and are known to pose risks during pregnancy. If you were receiving PUVA before pregnancy, your doctor will switch you to NB-UVB as the appropriate alternative.

The safety profiles of these two phototherapy modalities could not be more different. NB-UVB involves no systemic medication; PUVA does. This fundamental difference explains why NB-UVB is considered acceptable during pregnancy while PUVA is contraindicated.

How Vitiligo Behaves During Pregnancy

Understanding how vitiligo itself behaves during pregnancy can help you make informed treatment decisions.

According to the VR Foundation, most women with vitiligo remain stable during pregnancy — some even experience improvement. However, flare-ups can occur after childbirth as the immune system "resets," though these are usually temporary and manageable.

Regarding pregnancy outcomes, vitiligo itself does not make pregnancy unsafe. Studies show a possible small increase in miscarriage risk, but risks for preterm birth, pre-eclampsia, or stillbirth are not consistently higher in women with vitiligo compared to the general population.

Treatments to Avoid During Pregnancy

While NB-UVB is considered safe, several other vitiligo treatments are not recommended during pregnancy:

Treatment	Status	Why
PUVA	Avoid	Psoralens are mutagenic; not safe during pregnancy
Methotrexate	Contraindicated	Known teratogen causing birth defects and miscarriage; must be stopped 3–6 months before conception
Oral retinoids	Avoid	Can cause birth defects
Systemic immunosuppressants	Requires individual assessment	May cross the placenta; benefits must outweigh risks

Your dermatologist and obstetrician should review your entire treatment regimen — not just phototherapy — to ensure all medications and therapies are appropriate for pregnancy.

Breastfeeding and NB-UVB

If you are planning to breastfeed after delivery, NB-UVB remains a safe option. Phototherapy is considered safe for breastfeeding women, with no reports of UVB treatment harming a nursing infant. The UV light does not enter the bloodstream or breast milk, so there is no direct exposure to the baby.

Many women experience postpartum vitiligo flare-ups as hormone levels shift and the immune system adjusts. NB-UVB can be an effective treatment option during this period if needed.

Practical Steps: What to Discuss with Your Doctor

Before starting or continuing NB-UVB phototherapy during pregnancy, have a conversation with both your dermatologist and obstetrician covering these points:

Your current vitiligo status — Is it active and spreading, or stable?
Your trimester — Are you in the first, second, or third trimester?
Your folic acid supplementation — Are you taking an adequate dose, and should it be increased?
The extent of treatment — Do you need whole-body phototherapy, or can targeted treatment suffice?
Alternative options — Could topical treatments (like low-potency corticosteroids or calcineurin inhibitors) control your vitiligo without phototherapy?
Treatment frequency — How many sessions per week, and for how many weeks?

Narrowband UVB phototherapy is one of the safest treatment options available for managing vitiligo during pregnancy. Major medical institutions and dermatology guidelines classify it as generally safe, with no known teratogenic effects and no systemic drug exposure.

However, "safe" does not mean "no precautions." The most important medical advice doctors emphasize is folic acid supplementation to counteract UVB-induced folate depletion. Protecting your face from melasma, using targeted rather than whole-body treatment when possible, and following the lowest effective dose principle are also essential.

Every pregnancy is different, and every case of vitiligo has its own characteristics. Work closely with your dermatologist and obstetrician to create a treatment plan that protects both you and your baby. With proper medical supervision, NB-UVB can be an effective tool for managing vitiligo throughout your pregnancy journey.

Using Narrowband UVB for Vitiligo During Pregnancy: What Doctors Say

Get the latest price?